Is there anyone who DOESN'T thinkre-scheduling will have a huge impact.
The informed investors however, are intelligent enough to understand that re-scheduling does not legalize cannabis - and it has little impact on foreign cannabis companies - such as Tilray, ACB and Weed.
Why would US companies 'partner up' with Canadian LPs and not US MSOs - who've been operating in established, state legal markets for years? They're going to team up with companies that can't ship rec cannabis into the US?
Please provide support for your nonsensical, misleading statement that Coke, Pepsi, Kraft & J&J have expressed actual interest, instead of nonsense that 'it's been highly speculated'. Specualetd by who? You?
Nothingw rong woth being a 'long minded' investor in cannabis - the intelligent ones are long on US MSOs who'll benefit soon from rescheduling and SAFE, not dead in the water Canadian LPs
Comment by
quinlashon Jun 15, 2024 11:28am 
69 Views
Post# 36090511
RE:RE:Thanks again quinlash, for sharing your
RE-Scheduling of cannabis may be a bigger mover to the cannabis sector than many may first think. Yes, it is another step towards the full legalization of cannabis however it may also mark a turning point for many large investors to start entering Long Positions on their companies of choice.
Companies like Coke + Pepsi, Kraft and Johnson and Johnson have all been reported, or highly speculated on, in terms of interest for the development of Cannabis Drinks, cannabis Edibles and medical products.
Rescheduling of cannabis may be all that is needed for some of these large companies to start investing or partnering with cannabis companies. This may or may not lead these companies to develop products within the US however depending on the nature of what they plan to do it may be very straightforward for these companies to partner up with cannabis producers for product development within Canada.
Canadian LPs of notable size include Canopy Growth, Tilray Brands as well as Aurora Cannabis. Each of these have similarities but they also each have their own specialities and focus.
Medical and Rec are covered nicely by both Canopy and Tilray. Aurora Cannabis has focus on medical.
I firmly believe the cannabis sector is suffering from weak handed daytraders and over zealous novice short sellers.
Long term minded investors have a ripe menu of offerings to select from with many of the larger titles trading shares under actual book values.
I will not be commenting on shareprice, as everyone should understand the shareprice is not set by the company, it is set by the market. The market can present opportunities for both Long and Short position traders.
My view in the long-term is favorable and I only trade Long Positions. My opinion is that short position traders are playing a game of musical chairs to see who gets a margin call once the Cannabis Sector gets back into the media and fresh money starts flowing in again.